Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond.

STAT6 gain-of-function allergic inflammation atopic dermatitis inborn error of immunity precision therapeutics primary atopic disorder

Journal

Trends in immunology
ISSN: 1471-4981
Titre abrégé: Trends Immunol
Pays: England
ID NLM: 100966032

Informations de publication

Date de publication:
02 2024
Historique:
received: 07 12 2023
revised: 18 12 2023
accepted: 20 12 2023
medline: 11 2 2024
pubmed: 19 1 2024
entrez: 18 1 2024
Statut: ppublish

Résumé

Signal transducer and activator of transcription (STAT)-6 is a transcription factor central to pro-allergic immune responses, although the function of human STAT6 at the whole-organism level has long remained unknown. Germline heterozygous gain-of-function (GOF) rare variants in STAT6 have been recently recognized to cause a broad and severe clinical phenotype of early-onset, multi-system allergic disease. Here, we provide an overview of the clinical presentation of STAT6-GOF disease, discussing how dysregulation of the STAT6 pathway causes severe allergic disease, and identifying possible targeted treatment approaches. Finally, we explore the mechanistic overlap between STAT6-GOF disease and other monogenic atopic disorders, and how this group of inborn errors of immunity (IEIs) powerfully inform our fundamental understanding of common human allergic disease.

Identifiants

pubmed: 38238227
pii: S1471-4906(23)00263-6
doi: 10.1016/j.it.2023.12.003
pii:
doi:

Substances chimiques

STAT6 protein, human 0
STAT6 Transcription Factor 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

138-153

Investigateurs

Mehul Sharma (M)
Narissara Suratannon (N)
Daniel Leung (D)
Safa Baris (S)
Ichiro Takeuchi (I)
Simran Samra (S)
Kumiko Yanagi (K)
Jaime S Rosa Duque (JS)
Mehdi Benamar (M)
Kate L Del Bel (KL)
Mana Momenilandi (M)
Vivien Béziat (V)
Jean-Laurent Casanova (JL)
P Martin van Hagen (PM)
Katsuhiro Arai (K)
Ichiro Nomura (I)
Tadashi Kaname (T)
Pantipa Chatchatee (P)
Hideaki Morita (H)
Talal A Chatila (TA)
Yu Lung Lau (YL)
Stuart E Turvey (SE)

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no conflicts of interest pertinent to this review.

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH